• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 54-68 of 105 results

1024 Exhibit: Ex 1024 US Food and Drug Administration Good Review Practice

Document IPR2023-00478, No. 1024 Exhibit - Ex 1024 US Food and Drug Administration Good Review Practice (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1020 Exhibit: Ex 1020 Jennifer R Brown, et al

Document IPR2023-00478, No. 1020 Exhibit - Ex 1020 Jennifer R Brown, et al (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1013 Exhibit: Ex 1013 US Provisional Application No 62035,777

Document IPR2023-00478, No. 1013 Exhibit - Ex 1013 US Provisional Application No 62035,777 (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1009 Exhibit: Ex 1009 Ranjana H Advani, et al

Document IPR2023-00478, No. 1009 Exhibit - Ex 1009 Ranjana H Advani, et al (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1023 Exhibit: Ex 1023 Prosecution History of US Patent No 9,758,524 Part 1

Document IPR2023-00478, No. 1023 Exhibit - Ex 1023 Prosecution History of US Patent No 9,758,524 Part 1 (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1031 Exhibit: Ex 1031 Amit Mahipal, et al

Document IPR2023-00478, No. 1031 Exhibit - Ex 1031 Amit Mahipal, et al (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1036 Exhibit: Ex 1036 Jan de Jong, et al

Document IPR2023-00478, No. 1036 Exhibit - Ex 1036 Jan de Jong, et al (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1007 Exhibit: Ex 1007 US Provisional Application No 61509,397 to Barf, et al

Document IPR2023-00478, No. 1007 Exhibit - Ex 1007 US Provisional Application No 61509,397 to Barf, et al (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1033 Exhibit: Ex 1033 Toshio Yoshizawa, et al,

Document IPR2023-00478, No. 1033 Exhibit - Ex 1033 Toshio Yoshizawa, et al, (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1004 Exhibit: Ex 1004 Prosecution History of US Patent No 10,272,083 Part 6

Document IPR2023-00478, No. 1004-6 Exhibit - Ex 1004 Prosecution History of US Patent No 10,272,083 Part 6 (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1037 Exhibit: Ex 1037 Dominique Levêque

Document IPR2023-00478, No. 1037 Exhibit - Ex 1037 Dominique Levêque (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1025 Exhibit: Ex 1025 US Patent No 7,732,454

Document IPR2023-00478, No. 1025 Exhibit - Ex 1025 US Patent No 7,732,454 (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1039 Exhibit: Ex 1039 TASIGNA® nilotinib Prescribing Information

Document IPR2023-00478, No. 1039 Exhibit - Ex 1039 TASIGNA® nilotinib Prescribing Information (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1026 Exhibit: Ex 1026 International Conference on Harmonisation

Document IPR2023-00478, No. 1026 Exhibit - Ex 1026 International Conference on Harmonisation (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze

1001 Exhibit: Ex 1001 US Patent No 10,272,083 to Hamdy et al

Document IPR2023-00478, No. 1001 Exhibit - Ex 1001 US Patent No 10,272,083 to Hamdy et al (P.T.A.B. Feb. 3, 2023)

cite Cite Document
Analyze
<< 1 2 3 4 5 6 7 8 >>